Evidence map›Paper›PMID 16244829›Full record

SynthesisZeitschrift fur Rheumatologie2005

[Evidence-based evaluation of study results of symptomatic glucosamine therapy].

S Reiter

Abstract readEnglish AbstractMeta-AnalysisReview
PubMed Publisher
In one paragraph

Synthesis in Zeitschrift fur Rheumatologie, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

S ReiterBundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany.
Federal Institute for Drugs and Medical Devices · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meta-analyses can contribute to the field of evidence based medicine. In the systematic analyses so far published, the symptomatic efficacy of glucosamine was described to be moderate to large. The results of the individual clinical studies however do not support these findings unanimously. In the past couple of years, some new studies of high quality standard were published. This publication gives an overview and an evaluation of the current available studies for the symptomatic treatment of patients with gonarthrosis with glucosamine. It also compares the results of the individual studies with those of recent meta-analyses.

Indexed as

Analgesics, Non-NarcoticAntirheumatic AgentsArthralgiaClinical Trials as TopicComorbidityEvidence-Based MedicineGlucosamineHumansIncidenceOsteoarthritisPalliative CarePrognosisRisk AssessmentRisk FactorsTreatment OutcomeAnalgesics, Non-NarcoticAntirheumatic AgentsGlucosamine

Identifiers

PMID16244829
OpenAlexW1151523133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.